产品标题 产品货号 产品规格 厂家
Trdmt1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5181581 kitORIGENE TECHNOLOGIES
TRDN - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4215481 kitORIGENE TECHNOLOGIES
Trdn - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5181591 kitORIGENE TECHNOLOGIES
Treacher Collins-Franceschetti syndrome 1 (TCOF1), transcript variant 3 from ORIGENE TECHNOLOGIESLY423342100 ugORIGENE TECHNOLOGIES
Trefoil factor 3 (intestinal) (TFF3) from ORIGENE TECHNOLOGIESLY418823100 ugORIGENE TECHNOLOGIES
Trefoil factor 1 (TFF1) from ORIGENE TECHNOLOGIESLY418822100 ugORIGENE TECHNOLOGIES
Trefoil factor 2 (TFF2) from ORIGENE TECHNOLOGIESLY417317100 ugORIGENE TECHNOLOGIES
TREH - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4165991 kitORIGENE TECHNOLOGIES
Treh - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5181601 kitORIGENE TECHNOLOGIES
TREM2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN2211321 kitORIGENE TECHNOLOGIES
TREM2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN221132BN1 kitORIGENE TECHNOLOGIES
TREM2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN221132LP1 kitORIGENE TECHNOLOGIES
TREM2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN221132RB1 kitORIGENE TECHNOLOGIES
TREM1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4046271 kitORIGENE TECHNOLOGIES
TREM2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4211321 kitORIGENE TECHNOLOGIES
Trem1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5181611 kitORIGENE TECHNOLOGIES
Trem2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5181621 kitORIGENE TECHNOLOGIES
Trem3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5181631 kitORIGENE TECHNOLOGIES
TREML4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4110201 kitORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCS6062705x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCS6259985x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCS6308135x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCS6315935x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCS6369775x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7011015x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7011025x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7011295x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7021865x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7021875x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7024545x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8016485x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8016685x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8103275x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8151055x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8151065x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8151075x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS5037415x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS5080735x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS5347995x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS5566195x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCS7131215x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCS5425235x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCS6038195x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCS8003205x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCS8151085x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCS5402215x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Carcinoma of ovary, endometrioid from ORIGENE TECHNOLOGIESCS8047505x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Carcinoma of ovary, endometrioid from ORIGENE TECHNOLOGIESCS8047515x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Carcinoma of ovary, endometrioid from ORIGENE TECHNOLOGIESCS8047545x5umORIGENE TECHNOLOGIES
Human Ovary: bilateral; Carcinoma of ovary, endometrioid from ORIGENE TECHNOLOGIESCS8047565x5umORIGENE TECHNOLOGIES
 |< < 757 758 759 760 761 762 763 764 765 > >| 第 763/6274 页